Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoyaosan for euthyroid autoimmune thyroid disease with qi-stagnation constitution
ChiCTR2100054144Phase 4Not yet recruiting
- Sponsor
- Beijing Shijitan Hospital
- Start
- Oct 2020
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of xiao yao san in autoimmune thyroid disease (AITD) (2 arms), sponsored by Beijing Shijitan Hospital. Primary endpoints: thyroid hormones, thyroid autoantibodies and 1 more. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
xiao yao san
03
Conditions
autoimmune thyroid disease (AITD)
Beyond the preview
Go deeper on ChiCTR2100054144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054144.